Skip to main content
OpenTrials
Completed

NCT Number: NCT02140567

Syncope Prediction Study

The purpose of this study is to perform a prospective evaluation of the vasovagal syncope prediction algorithm, called Tilt Test Analyzer, during head up tilt testing tests in one center in the United Kingdom.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Hammersmith Hospital, Imperial College Healthcare NHS Trust

London, United Kingdom

About this study

Vasovagal syncope (VVS) is a form of neurally-mediated reflex syncope, which is marked by a sudden fall in blood pressure with an associated fall in heart rate often resulting in syncope, head-up tilt (HUT) testing is commonly used to bring information about VVS using ECG and blood pressure monitoring with medical observation.

We developed an algorithm, called Tilt Test Analyzer, to predict VVS during HUT based on the simultaneous analysis of heart rate (RR interval), systolic blood pressure (SBP) and an indicator of autonomic modulation represented by heart rate and blood pressure variability (HRV and BPV).

The primary objective of this study is to evaluate the VVS prediction algorithm in a prospective cohort of patients in the tilt laboratory The primary endpoint is the VVS prediction algorithm performance by means of measuring the sensitivity and specificity values.

The study is designed to test if the prospective analysis of tilt-test patients can reproduce the results previously obtained in the published retrospective analysis on 1155 patients with a similar clinically relevant sensitivity and specificity.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients referred to the center with vasovagal syncope for tilt testing.
  • The patient is willing and able to cooperate with the study procedures.
  • The subject or legal guardian is able to provide written informed consent

Exclusion criteria

  • Patients under 18 years or over 90 years old.
  • Women who are currently pregnant or have a positive pregnancy test.
  • Patients who had a prior tilt test.
  • Patients enrolled in another device or drug study.

Treatment and study plan

Primary outcomes

  1. Sensitivity of the Syncope Prediction Algorithm

    Time frame: Tilt Test with average duration of 1 hour

    Number of tilt-positive participants predicted in the right way by the syncope prediction algorithm

  2. Specificity of the Syncope Prediction Algorithm

    Time frame: Tilt Test with average duration of 1 hour

    Number of tilt-negative participants identified as negative by the syncope prediction algorithm

Sponsors and collaborators

Lead sponsor

Medtronic BRC

Industry

Registry information

Acronym: SPS

Important dates

Study start
2014
Primary completion
2016
Study completion
2016
First posted
May 16, 2014
Registry last updated
Mar 15, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.